Screener
ResMed RMD Treasury Stock
Treasury Stock at other companies
Other financials
Where this comes from
Reported directly by ResMed in its filing.
Tagged under the XBRL concept us-gaap:TreasuryStockCommonValue.
The source filing: ResMed’s 8-K, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:05 PM EDT
- Accession
- 0001193125-26-337962
FAQ
- What is ResMed's treasury stock?
- ResMed (RMD) reported treasury stock of -$2.78B in Q2 2026.
- How has ResMed's treasury stock changed year-over-year?
- ResMed's treasury stock decreased by 234.0% year-over-year, from $2.07B to -$2.78B.
- What is the long-term trend for ResMed's treasury stock?
- Over 5 years (2021 to 2026), ResMed's treasury stock has grown at a 11.3% compound annual growth rate (CAGR), from $1.62B to -$2.78B.
- What does treasury stock mean?
- Shares repurchased by the company and held in treasury, reducing equity. Recorded at cost and presented as a negative equity component.
Ask your AI about ResMed's treasury stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude